Puma Biotechnology Inc. | BioWorld
Puma Biotechnology Announces New Updates And Changes In Breast Cancer Treatment
Puma Biotechnology, Inc. | LinkedIn
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotechnology
PumaBiotech (@pumabiotech) / Twitter
Puma Biotechnology Presents Final Results from the Biliary Tract Cohort of the Phase 2 SUMMIT 'Basket' Trial of Neratinib at the ASCO 2022 Annual Meeting
Puma Biotechnology
Puma Biotechnology (PBYI) Presents At Barclays Global Healthcare Virtual Conference (NASDAQ:PBYI) | Seeking Alpha
Exhibitor Puma Biotechnology 07-10 - Scripps CME Connection
Puma Biotechnology
Puma Biotechnology, Inc. 2022 Q1 - Results - Earnings Call Presentation (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology Reports Results of PB272 (neratinib) in P-III NALA Trial for Patients with 2L+ HER2+ Metastatic Breast Cancer #ASCO2019
Puma Biotechnology and Pierre Fabre Enter into Exclusive License Agreement to Develop and Commercialize NERLYNX® (neratinib) in Europe | Business Wire
Henry Kuo - Head of Information Technology - Puma Biotechnology, Inc. | LinkedIn
Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology to Present at the Cantor Virtual Global Healthcare Conference | Business Wire
PumaBiotech (@pumabiotech) / Twitter
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | citybiz
Former Puma Biotech executive gets U.S. prison term for insider trading | Reuters
Puma Biotechnology, Inc. | LinkedIn
